Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis

References

• Ding Y, Tan Y, Qu Z, et al. Renal microvascular lesions in lupus nephritis. Ren Fail. 2020;42(1):19–29.
   PubMed Web of Science ®Google Scholar
• Kwok SK, Tsokos GC. New insights into the role of renal resident cells in the pathogenesis of lupus nephritis. Korean J Intern Med. 2018;33(2):284–289.
   PubMed Web of Science ®Google Scholar
• Monroy Trujillo JM, DM. Fine Management of proliferative lupus nephritis. Panminerva Med. 2016;58(4):286–293.
   PubMed Web of Science ®Google Scholar
• Almaani S, Meara A, Rovin BH. Update on Lupus Nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–835.
   PubMed Web of Science ®Google Scholar
• Tektonidou MG, Dasgupta A, Ward MM. Risk of end-stage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and bayesian meta-analysis. Arthritis Rheumatol. 2016;68(6):1432–1441.
   PubMed Web of Science ®Google Scholar
• Goilav B, Putterman C, Rubinstein TB. Biomarkers for kidney involvement in pediatric lupus. Biomark Med. 2015;9(6):529–543.
   PubMed Web of Science ®Google Scholar
• Tunnicliffe DJ, Singh-Grewal D, Kim S, et al. Diagnosis, monitoring, and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines. Arthritis Care Res. 2015;67(10):1440–1452.
   PubMed Web of Science ®Google Scholar
• Leung YY, Szeto CC, Tam LS, et al. Urine protein-to-creatinine ratio in an untimed urine collection is a reliable measure of proteinuria in lupus nephritis. Rheumatology. 2006;46(4):649–652.
   PubMed Web of Science ®Google Scholar
• Mok CC. Biomarkers for lupus nephritis: a critical appraisal. J Biomed Biotechnol. 2010;2010:638413
   PubMedGoogle Scholar
• Koutsonikoli A, Trachana M, Farmaki E, et al. Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis. Clin Exp Immunol. 2017;188(1):79–85.
   PubMed Web of Science ®Google Scholar
• Wiley SR, Cassiano L, Lofton T, et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity. 2001;15(5):837–846.
   PubMed Web of Science ®Google Scholar
• Maecker H, Varfolomeev E, Kischkel F, et al. TWEAK attenuates the transition from innate to adaptive immunity. Cell. 2005;123(5):931–944.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Burkly LC, Campbell S, et al. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol. 2007;179(11):7949–7958.
   PubMed Web of Science ®Google Scholar
• Xia Y, Campbell SR, Broder A, et al. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. Clin Immunol. 2012;145(2):108–121.
   PubMed Web of Science ®Google Scholar
• Xia Y, Herlitz LC, Gindea S, et al. Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis. J Am Soc Nephrol. 2015;26(5):1053–1070.
   PubMed Web of Science ®Google Scholar
• Lu J, Kwan BC-H, Lai FM-M, et al. Gene expression of TWEAK/Fn14 and IP-10/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis. Nephrology. 2011;16(4):426–432.
   PubMed Web of Science ®Google Scholar
• Liu Z-C, Zhou Q-L, Li X-Z, et al. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Cytokine. 2011;53(3):295–300.
   PubMed Web of Science ®Google Scholar
• Reyes-Thomas J, Blanco I, Putterman C. Urinary biomarkers in lupus nephritis. Clin Rev Allergy Immunol. 2011;40(3):138–150.
   PubMed Web of Science ®Google Scholar
• Dhaun N, Kluth DC. TWEAK: a novel biomarker for lupus nephritis? Arthritis Res Ther. 2009;11(6):133.
   PubMed Web of Science ®Google Scholar
• Mirioglu S, Cinar S, Yazici H, et al. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus. Lupus. 2020;29(4):379–388.
   PubMed Web of Science ®Google Scholar
• Schwartz N, Rubinstein T, Burkly LC, et al. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther. 2009;11(5):R143.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–1277.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Petri M, Orbai A-M, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–2686.
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
   PubMed Web of Science ®Google Scholar
• Xuejing Z, Jiazhen T, Jun L, et al. Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases. J Biomed Biotechnol. 2012;2012:359647.
   PubMedGoogle Scholar
• McMahon M, Skaggs BJ, Grossman JM, et al. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheumatol. 2014;66(1):130–139.
   PubMed Web of Science ®Google Scholar
• Suttichet TB, Kittanamongkolchai W, Phromjeen C, et al. Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study. Lupus Sci Med. 2019;6(1):e000298.
   PubMed Web of Science ®Google Scholar
• Zhi-Chun L, Qiao-Ling Z, Zhi-Qin L, et al. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis. Inflammation. 2012;35(3):935–943.
   PubMed Web of Science ®Google Scholar
• El-Shehaby A, Darweesh H, El-Khatib M, et al. Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis. J Clin Immunol. 2011;31(5):848–856.
   PubMed Web of Science ®Google Scholar
• Choe JY, Kim SK. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus. Inflamm Res. 2016;65(6):479–488.
   PubMed Web of Science ®Google Scholar
• Reyes-Martínez F, Pérez-Navarro M, Rodríguez-Matías A, et al. Assessment of urinary TWEAK levels in Mexican patients with untreated lupus nephritis: an exploratory study. Nefrologia. 2018;38(2):152–160.
   PubMed Web of Science ®Google Scholar
• Dong XW, Zheng ZH, Ding J, et al. Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis. Lupus. 2018;27(6):971–981.
   PubMed Web of Science ®Google Scholar
• Dong X, Zheng Z, Luo X, et al. Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: a case-control study. Medicine. 2018;97(16):e0343.
   PubMed Web of Science ®Google Scholar
• Salem MN, Taha HA, Abd El-Fattah El-Feqi M, et al. Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis. Z Rheumatol. 2018;77(1):71–77.
   PubMed Web of Science ®Google Scholar
• Tan J. The relationship between urinary TWEAK level and the activity of lupus nephritis (in Chinese). [MA thesis]. Central South University; 2009. https://kns.cnki.net/KCMS/detail/detail.aspx?dbname=CMFD2010&filename=2009240264.nh
   Google Scholar
• Soliman S, Mohan C. Lupus nephritis biomarkers. Clin Immunol. 2017;185:10–20.
   PubMed Web of Science ®Google Scholar
• Wang S, Shang J, Xiao J, et al. Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody. Ren Fail. 2020;42(1):244–254.
   PubMed Web of Science ®Google Scholar
• He D, Liu M, Liu B. Interleukin-35 as a new biomarker of renal involvement in lupus nephritis patients. Tohoku J Exp Med. 2018;244(4):263–270.
   PubMed Web of Science ®Google Scholar
• Mok CC, Soliman S, Ho LY, et al. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis. Arthritis Res Ther. 2018;20(1):6.
   PubMed Web of Science ®Google Scholar
• Turnier JL, Fall N, Thornton S, et al. Urine S100 proteins as potential biomarkers of lupus nephritis activity. Arthritis Res Ther. 2017;19(1):242.
   PubMedGoogle Scholar
• Cardenas-Gonzalez M, Srivastava A, Pavkovic M, et al. Identification, confirmation, and replication of novel urinary microrna biomarkers in lupus nephritis and diabetic nephropathy. Clin Chem. 2017;63(9):1515–1526.
   PubMed Web of Science ®Google Scholar
• Birmingham DJ, Merchant M, Waikar SS, et al. Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise. Nephrol Dial Transplant. 2017;32(suppl_1):i71–i79.
   PubMedGoogle Scholar
• Sanz AB, Sanchez-Niño MD, Ortiz A. TWEAK, a multifunctional cytokine in kidney injury. Kidney Int. 2011;80(7):708–718.
   PubMed Web of Science ®Google Scholar
• Burkly LC, Michaelson JS, Zheng TS. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses. Immunol Rev. 2011;244(1):99–114.
   PubMedGoogle Scholar
• Xu WD, Zhao Y, Liu Y. Role of the TWEAK/Fn14 pathway in autoimmune diseases. Immunol Res. 2016;64(1):44–50.
   PubMed Web of Science ®Google Scholar
• Sidler D, Wu P, Herro R, et al. TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis. Nat Commun. 2017;8:15395.
   PubMed Web of Science ®Google Scholar
• Leng R-X, Pan H-F, Qin W-Z, et al. TWEAK as a target for therapy in systemic lupus erythematosus. Mol Biol Rep. 2011;38(1):587–592.
   PubMed Web of Science ®Google Scholar
• Chen J, Jia F, Ren K, et al. Inhibition of suppressor of cytokine signaling 1 mediates the profibrotic effect of TWEAK/Fn14 signaling on kidney cells. Cell Signal. 2020;71:109615.
   PubMed Web of Science ®Google Scholar
• Utsch B, Klaus G. Urinalysis in children and adolescents. Dtsch Arztebl Int. 2014;111(37):617–625.
   PubMed Web of Science ®Google Scholar
• Courtemanche K, Chan P, Kassouf W. Prevalence and associated factors for dipstick microscopic hematuria in men. BMC Urol. 2019;19(1):76.
   PubMed Web of Science ®Google Scholar
• Bajema IM, Wilhelmus S, Alpers CE, et al. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018;93(4):789–796.
   PubMed Web of Science ®Google Scholar
• Pickering RMJBJoSM. Biostatistics and epidemiology: a primer for health professionals. Biostatist Epidemiol. 1991;45(2):174–174.
   Google Scholar